{"id":47184,"date":"2019-01-31T15:30:46","date_gmt":"2019-01-31T21:30:46","guid":{"rendered":"https:\/\/www.crescentcityjewishnews.com\/?p=47184"},"modified":"2019-01-31T15:30:46","modified_gmt":"2019-01-31T21:30:46","slug":"an-israeli-company-claims-to-have-a-cure-for-cancer-but-fellow-scientists-say-not-so-fast","status":"publish","type":"post","link":"https:\/\/www.crescentcityjewishnews.com\/blog\/an-israeli-company-claims-to-have-a-cure-for-cancer-but-fellow-scientists-say-not-so-fast\/","title":{"rendered":"An Israeli company claims to have a cure for cancer, but fellow scientists say not so fast"},"content":{"rendered":"<p>By MARCY OSTER<\/p>\n<p>JERUSALEM (JTA) \u2014 A team of scientists at a biotech company in Israel claimed that they will have a cure for cancer \u2014 all cancer \u2014 within a year.<\/p>\n<p>Sadly, their claims were shot down by fellow scientists.<\/p>\n<p>In recent articles in Israel and the United States, Accelerated Evolution Biotechnologies Ltd., or AEBi, which was founded in 2000 from the ITEK Weizmann technology incubator, announced that a new treatment being developed by the company would offer a complete cure for cancer with \u201cno or minimal side-effects at a much lower cost than most other treatments on the market.\u201d<\/p>\n<p>The treatment, according to Dan Aridor, chairman of the board of AEBi, and CEO Dr. Ilan Morad \u2014 which they call MuTaTo, or multi-target toxin \u2014 works essentially like a cancer antibiotic, they told the Jerusalem Post.&nbsp;They said the results of pre-clinical trials have been very good.<\/p>\n<p>But fellow scientists quickly rejected the claims, calling them \u201cspurious,\u201d \u201chighly irresponsible,\u201d \u201cunsubstantiated\u201d and even \u201ccruel.\u201d<\/p>\n<p>The skeptical scientists note that the research group has not published any findings to back up their claims, as is traditional in the science community.<\/p>\n<p>Morad told The Times of Israel earlier this week that it has not published its research in medical journals because it \u201ccan\u2019t afford\u201d to do so.<\/p>\n<p>But reputable scientific journals, that are peer-reviewed and highly respected, do not charge to publish serious scientific research, though the process can be rigorous.<\/p>\n<p>Writing in Forbes, Victoria Forster, a cancer researcher and child cancer survivor, called AEBI less than forthcoming with information about their alleged cure.<\/p>\n<p>\u201cDelving into what the company does supply,&nbsp;there are two graphs and some pictures taken down a microscope, much less than I provided from a 6-week undergraduate research project a decade ago,\u201d she wrote.<\/p>\n<p>She also calls a claim that one cure will work for all of the over 200 different types of cancer out there a \u201chuge red flag\u201d that such a claim is \u201chighly unlikely.\u201d<\/p>\n<p>Meanwhile, she notes, the&nbsp;American Cancer Society published a blog&nbsp;article from their deputy chief medical officer explaining why the company\u2019s claims are unlikely to be true, including that their approach isn\u2019t that unique and that other similar approaches have failed.<\/p>\n<p>The CEO of the Israel Advanced Technology Industries group said the whole situation has \u201cdamaged the image of Israel\u2019s life sciences industry.\u201d<\/p>\n<p>So far, the tests have also only been conducted on mice, not on humans, although the scientists told the Jerusalem Post that their results are \u201cconsistent and repeatable.\u201d The company told The Times of Israel that it plans to advance its research and get to clinical trials as fast as possible.<\/p>\n<div style=\"padding-bottom:20px; padding-top:10px;\" class=\"hupso-share-buttons\"><!-- Hupso Share Buttons - https:\/\/www.hupso.com\/share\/ --><a class=\"hupso_toolbar\" href=\"https:\/\/www.hupso.com\/share\/\"><img decoding=\"async\" data-src=\"https:\/\/static.hupso.com\/share\/buttons\/share-medium.png\" style=\"border:0px; padding-top: 5px; float:left;\" alt=\"Share Button\" src=\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\" class=\"lazyload\" \/><noscript><img decoding=\"async\" src=\"https:\/\/static.hupso.com\/share\/buttons\/share-medium.png\" style=\"border:0px; padding-top: 5px; float:left;\" alt=\"Share Button\"\/><\/noscript><\/a><script type=\"text\/javascript\">var hupso_services_t=new Array(\"Twitter\",\"Facebook\",\"Google Plus\",\"Pinterest\",\"Linkedin\",\"Tumblr\",\"Email\");var hupso_background_t=\"#EAF4FF\";var hupso_border_t=\"#66CCFF\";var hupso_toolbar_size_t=\"medium\";var hupso_image_folder_url = \"\";var hupso_url_t=\"\";var hupso_title_t=\"An%20Israeli%20company%20claims%20to%20have%20a%20cure%20for%20cancer%2C%20but%20fellow%20scientists%20say%20not%20so%20fast\";<\/script><script type=\"text\/javascript\" src=\"https:\/\/static.hupso.com\/share\/js\/share_toolbar.js\"><\/script><!-- Hupso Share Buttons --><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[27],"tags":[82,8781,8790,8795,8788],"_links":{"self":[{"href":"https:\/\/www.crescentcityjewishnews.com\/blog\/wp-json\/wp\/v2\/posts\/47184"}],"collection":[{"href":"https:\/\/www.crescentcityjewishnews.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.crescentcityjewishnews.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.crescentcityjewishnews.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.crescentcityjewishnews.com\/blog\/wp-json\/wp\/v2\/comments?post=47184"}],"version-history":[{"count":1,"href":"https:\/\/www.crescentcityjewishnews.com\/blog\/wp-json\/wp\/v2\/posts\/47184\/revisions"}],"predecessor-version":[{"id":47185,"href":"https:\/\/www.crescentcityjewishnews.com\/blog\/wp-json\/wp\/v2\/posts\/47184\/revisions\/47185"}],"wp:attachment":[{"href":"https:\/\/www.crescentcityjewishnews.com\/blog\/wp-json\/wp\/v2\/media?parent=47184"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.crescentcityjewishnews.com\/blog\/wp-json\/wp\/v2\/categories?post=47184"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.crescentcityjewishnews.com\/blog\/wp-json\/wp\/v2\/tags?post=47184"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}